Mimicking the Impact of Infant Tongue Peristalsis on Behavior of Solid Oral Dosage Forms Administered During Breastfeeding.
An in vitro simulation system was developed to study the effect of an infant's peristaltic tongue motion during breastfeeding on oral rapidly disintegrating tablets in the mouth, for use in rapid product candidate screening. These tablets are being designed for use inside a modified nipple shield worn by a mother during breastfeeding, a proposed novel platform technology to administer drugs and nutrients to breastfeeding infants. In this study, the release of a model compound, sulforhodamine B, from tablet formulations was studied under physiologically relevant forces induced by compression and rotation of a tongue mimic. The release profiles of the sulforhodamine B in flowing deionized water were found to be statistically different using 2-way ANOVA with matching, when tongue mimic rotation was introduced for 2 compression levels representing 2 tongue strengths (p = 0.0013 and p < 0.0001 for the lower and higher compression settings, respectively). Compression level was found to be a significant factor for increasing model compound release at rotational rates representing nonnutritive breastfeeding (p = 0.0162). This novel apparatus is the first to simulate the motion and pressures applied by the tongue and could be used in future infant oral product development.
Department of Chemical Engineering and Biotechnology, BioScience Engineering Research Group, University of Cambridge, New Museums Site, Cambridge, UK. Electronic address: rebekah.scheuerle@gmail.com.
Rebekah L
RL
Scheuerle
Department of Pharmaceutics, School of Pharmacy, University College London, London, UK.
Richard A
RA
Kendall
Department of Pharmaceutics, School of Pharmacy, University College London, London, UK.
Catherine
C
Tuleu
Department of Chemical Engineering and Biotechnology, BioScience Engineering Research Group, University of Cambridge, New Museums Site, Cambridge, UK.
Nigel K H
NKH
Slater
Department of Chemical Engineering and Biotechnology, BioScience Engineering Research Group, University of Cambridge, New Museums Site, Cambridge, UK.
Stephen E
SE
Gerrard
D001942:Breast Feeding; D016503:Drug Delivery Systems / Q000295:instrumentation* / Q000379:methods; D065546:Drug Liberation; D004867:Equipment Design; D006801:Humans; D007223:Infant; D010528:Peristalsis; D004364:Pharmaceutical Preparations / Q000008:administration & dosage* / Q000737:chemistry; D012235:Rhodamines / Q000008:administration & dosage / Q000737:chemistry; D013607:Tablets; D014059:Tongue / Q000502:physiology*
D004364:Pharmaceutical Preparations; D012235:Rhodamines; D013607:Tablets; C022027:lissamine rhodamine B
drug delivery systems; in vitro models; oral drug delivery; pediatric; physical characterization
Int J Pharm. 2015;486(1-2):136-43
25791759
Eur J Pharm Sci. 2004 Jun;22(2-3):165-72
15158901
Midwifery. 1986 Dec;2(4):164-71
3643397
J Pharm Sci. 2013 Oct;102(10):3773-83
23934768
Chem Pharm Bull (Tokyo). 2006 Aug;54(8):1072-5
16880646
J Hum Lact. 2015 Feb;31(1):68-75
25412617
Bull Math Biol. 1997 Sep;59(5):953-73
9281906
Early Hum Dev. 1991 Dec;27(3):163-73
1802669
Chem Pharm Bull (Tokyo). 2002 Sep;50(9):1181-6
12237533
Early Hum Dev. 1997 Oct 29;49 Suppl:S7-28
9363415
J Hum Lact. 1997 Sep;13(3):195-202
9341411
Pediatrics. 2004 Feb;113(2):361-7
14754950
Biotechnol Bioeng. 2013 Jul;110(7):2058-62
23436242
Early Hum Dev. 2012 Jun;88(6):443-9
22119233